Terms: = Bone cancer AND SDHD, PGL1, 6392, ENSG00000204370, PGL, SDH4, CBT1, O14521
41 results:
1. Tumor progression in tympanojugular paragangliomas: the role of radiotherapy and wait and scan.
Fancello G; Fancello V; Ehsani D; Porpiglia V; Piras G; Caruso A; Sanna M
Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):2779-2789. PubMed ID: 38184495
[TBL] [Abstract] [Full Text] [Related]
2. [68Ga]-DOTATATE PET/MRI in the diagnosis and management of recurrent head and neck paraganglioma with spinal metastasis.
Kim SH; Roytman M; Kamen E; Skafida M; Strauss S; Lin E; Kutler D; Zan E; Ivanidze J
Clin Imaging; 2021 Nov; 79():314-318. PubMed ID: 34392071
[TBL] [Abstract] [Full Text] [Related]
3. Approach to pheochromocytoma and paraganglioma in children and adolescents: A retrospective clinical study from a tertiary care center.
Ardicli B; User IR; Ciftci AÖ; Akyuz C; Kutluk MT; Gonc N; Ozon ZA; Alikasifoglu A; Oguz B; Haliloğlu M; Orhan D; Tanyel FC; Karnak I; Ekinci S
J Pediatr Urol; 2021 Jun; 17(3):400.e1-400.e7. PubMed ID: 33593626
[TBL] [Abstract] [Full Text] [Related]
4. False Positive of
Zampetti B; Attanasio R; Boniardi M; Cozzi R
Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1352-1355. PubMed ID: 32955005
[TBL] [Abstract] [Full Text] [Related]
5. Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.
Ilanchezhian M; Jha A; Pacak K; Del Rivero J
Curr Treat Options Oncol; 2020 Aug; 21(11):85. PubMed ID: 32862332
[TBL] [Abstract] [Full Text] [Related]
6. Role of deteriorated bone quality in the development of osteoporosis in pheochromocytoma and paraganglioma.
Yokomoto-Umakoshi M; Umakoshi H; Sakamoto R; Fukumoto T; Ogata M; Nakano Y; Iwahashi N; Kaneko H; Mizoguchi N; Hattori A; Miyazawa T; Matsuda Y; Kawate H; Ogawa Y;
Bone; 2021 Jan; 142():115607. PubMed ID: 32829039
[TBL] [Abstract] [Full Text] [Related]
7. Multiple metabolic parameters and visual assessment of
Ren Y; Liu J; Wang L; Luo Y; Ding X; Shi A; Liu J
Abdom Radiol (NY); 2020 Nov; 45(11):3569-3580. PubMed ID: 32274551
[TBL] [Abstract] [Full Text] [Related]
8. Pheochromocytoma and paraganglioma: An emerging cause of secondary osteoporosis.
Yokomoto-Umakoshi M; Umakoshi H; Fukumoto T; Matsuda Y; Nagata H; Ogata M; Kawate H; Miyazawa T; Sakamoto R; Ogawa Y;
Bone; 2020 Apr; 133():115221. PubMed ID: 31940499
[TBL] [Abstract] [Full Text] [Related]
9.
Kroiss AS; Uprimny C; Shulkin BL; Gruber L; Frech A; Jazbec T; Girod PP; Url C; Thomé C; Riechelmann H; Sprinzl GM; Fraedrich G; Virgolini IJ
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(2):94-99. PubMed ID: 30630744
[TBL] [Abstract] [Full Text] [Related]
10. Paraganglioma as a risk factor for bone metastasis.
Yokomoto-Umakoshi M; Umakoshi H; Tsuiki M; Ogasawara T; Hamanaka-Hiroshima K; Tanabe A; Tagami T; Shimatsu A; Naruse M
Endocr J; 2018 Mar; 65(3):253-260. PubMed ID: 29187703
[TBL] [Abstract] [Full Text] [Related]
11. Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma.
Ferrara AM; Lombardi G; Pambuku A; Meringolo D; Bertorelle R; Nardin M; Schiavi F; Iacobone M; Opocher G; Zagonel V; Zovato S
Anticancer Drugs; 2018 Jan; 29(1):102-105. PubMed ID: 29099418
[TBL] [Abstract] [Full Text] [Related]
12. Mandibular Lytic Lesion in Familial Paraganglioma Syndrome Type I: A Clinical Conundrum.
Sinha P; Yuen SN; Chernock RD; Haughey BH
Ann Otol Rhinol Laryngol; 2017 Aug; 126(8):615-618. PubMed ID: 28670912
[TBL] [Abstract] [Full Text] [Related]
13. [A retrospective analysis of clinical characteristics and prognostic factors for 124 cases of primary gastric lymphomas].
He Y; Wang L; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Cao L; Fan L; Li JY; Xu W
Zhonghua Xue Ye Xue Za Zhi; 2017 Jun; 38(6):505-510. PubMed ID: 28655094
[No Abstract] [Full Text] [Related]
14. Conventional Risk Stratification Fails to Predict Progression of Succinate Dehydrogenase-deficient Gastrointestinal Stromal Tumors: A Clinicopathologic Study of 76 Cases.
Mason EF; Hornick JL
Am J Surg Pathol; 2016 Dec; 40(12):1616-1621. PubMed ID: 27340750
[TBL] [Abstract] [Full Text] [Related]
15. Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma.
Fanelli M; Hattinger CM; Vella S; Tavanti E; Michelacci F; Gudeman B; Barnett D; Picci P; Serra M
Curr Cancer Drug Targets; 2016; 16(3):261-74. PubMed ID: 26548759
[TBL] [Abstract] [Full Text] [Related]
16. AN AGGRESSIVE TEMPORAL bone SDHC PARAGANGLIOMA ASSOCIATED WITH INCREASED HIF-2α SIGNALING.
Isaacson B; Bullova P; Frone M; Click A; Hamplova B; Rabaglia J; Woodruff S; Nwariaku F; Kathuria A; Pacak K; Ghayee HK
Endocr Pract; 2016 Feb; 22(2):190-5. PubMed ID: 26492543
[TBL] [Abstract] [Full Text] [Related]
17. Circulating Levels of Urokinase-Type Plasminogen Activator Receptor and D-Dimer in Patients With Hematological Malignancies.
Rubio-Jurado B; Tello-González A; Bustamante-Chávez L; de la Peña A; Riebeling-Navarro C; Nava-Zavala AH
Clin Lymphoma Myeloma Leuk; 2015 Oct; 15(10):621-6. PubMed ID: 26423703
[TBL] [Abstract] [Full Text] [Related]
18. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
[TBL] [Abstract] [Full Text] [Related]
19. (68)Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to (123)I-MIBG SPECT/CT.
Kroiss A; Shulkin BL; Uprimny C; Frech A; Gasser RW; Url C; Gautsch K; Madleitner R; Nilica B; Sprinzl GM; Gastl G; Fraedrich G; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):33-41. PubMed ID: 25134670
[TBL] [Abstract] [Full Text] [Related]
20. Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo.
Hao Z; Fan W; Hao J; Wu X; Zeng GQ; Zhang LJ; Nie SF; Wang XD
Drug Deliv; 2016; 23(3):874-81. PubMed ID: 24892627
[TBL] [Abstract] [Full Text] [Related]
[Next]
